Spots Global Cancer Trial Database for trivalent influenza vaccine
Every month we try and update this database with for trivalent influenza vaccine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia | NCT00022035 | Infection Leukemia | trivalent influ... | 1 Year - 20 Years | Roswell Park Cancer Institute | |
| Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia | NCT00022035 | Infection Leukemia | trivalent influ... | 1 Year - 20 Years | Roswell Park Cancer Institute | |
| Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | NCT02518555 | Chronic Lymphoc... Small Lymphocyt... | Diphtheria Toxo... Ibrutinib Laboratory Biom... Pharmacological... Pneumococcal 13... Quality-of-Life... Trivalent Influ... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors | NCT01941758 | Central Nervous... | trivalent influ... laboratory biom... | 18 Years - | Wake Forest University Health Sciences | |
| High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors | NCT01941758 | Central Nervous... | trivalent influ... laboratory biom... | 18 Years - | Wake Forest University Health Sciences | |
| Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders | NCT04080531 | Plasma Cell Neo... | Pneumococcal 13... Trivalent Influ... | 18 Years - | Emory University | |
| Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | NCT02518555 | Chronic Lymphoc... Small Lymphocyt... | Diphtheria Toxo... Ibrutinib Laboratory Biom... Pharmacological... Pneumococcal 13... Quality-of-Life... Trivalent Influ... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Cholecalciferol and Flu Vaccine in Treating Healthy Participants | NCT01561989 | Healthy, no Evi... | cholecalciferol questionnaire a... trivalent influ... | 18 Years - 64 Years | Roswell Park Cancer Institute | |
| Cholecalciferol and Flu Vaccine in Treating Healthy Participants | NCT01561989 | Healthy, no Evi... | cholecalciferol questionnaire a... trivalent influ... | 18 Years - 64 Years | Roswell Park Cancer Institute | |
| Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors | NCT02747407 | Astrocytoma Glioma Oligodendroglio... | Hepatitis A Vac... Laboratory Biom... Tetanus Toxoid ... Trivalent Influ... | 18 Years - | Wake Forest University Health Sciences |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
